Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
8.56
-0.18 (-2.06%)
At close: Apr 28, 2026, 4:00 PM EDT
8.73
+0.17 (1.99%)
After-hours: Apr 28, 2026, 4:19 PM EDT
Eikon Therapeutics Market Cap
Eikon Therapeutics has a market cap or net worth of $463.43 million as of April 28, 2026.
Market Cap
463.43M
Enterprise Value
384.77M
1-Year Change
n/a
Ranking
Category
Stock Price
$8.56
Market Cap Chart
Since the IPO on February 5, 2026, Eikon Therapeutics's market cap has decreased from $971.72M to $463.43M, a decrease of -52.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 463.43M | -52.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 538.54M |
| Tectonic Therapeutic | 535.88M |
| enGene Therapeutics | 535.25M |
| Lyell Immunopharma | 522.79M |
| Immix Biopharma | 522.17M |
| Fulcrum Therapeutics | 522.15M |
| Verastem | 519.15M |
| Zura Bio | 510.46M |